Stay updated on Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.

Latest updates to the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page
- Check6 days agoChange DetectedRevision v3.4.3 was added to the history and the entry for v3.4.2 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history; the notices about funding and operating status and the prior Revision: v3.4.1 entry were removed. These are administrative updates that do not alter the core study content or data on the page.SummaryDifference0.8%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding was added and the page revision label updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check48 days agoChange DetectedGlossary visibility is added and change diffs are shown with color highlights (green for additions, red for deletions), and the revision label updated to v3.4.0.SummaryDifference1%

- Check84 days agoChange DetectedRevision: v3.3.3 was added to the record history, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' entries were removed from the footer/versions view; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check106 days agoChange DetectedRecord History now shows Revision: v3.3.2 in place of Revision: v3.3.1. This is a minor UI label change and does not affect study data or functionality.SummaryDifference0.1%

Stay in the know with updates to Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.